RDHL
Redhill Biopharma
$0.70
+$0.07 (+10.58%)Jul 27, 2026
Key metrics
The numbers that frame RDHL today
- Market cap
- $0.00
- P/E (TTM)
- -0.0
- EV / FCF
- 0.3
- Gross margin
- 100%
- EV / Sales
- -10.1
- ROIC
- 3.6%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $0.63
- 52wk High
- $2.79
Growth
Revenue and earnings trend for RDHL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RDHL
Is Redhill Biopharma a good buy?
No. Redhill Biopharma has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of RDHL?
Redhill Biopharma's market capitalization is $0.00.
What is the P/E ratio for RDHL stock?
Redhill Biopharma's current P/E ratio is -0.
What is the 52-week high for RDHL stock?
The 52-week high for Redhill Biopharma is $2.79. The current close of $0.70 is 74.9% below that high.
What is the 52-week low for RDHL stock?
The 52-week low for Redhill Biopharma is $0.63. The current close of $0.70 is 11.1% above that low.
Does RDHL stock pay dividends?
Redhill Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RDHL?
Redhill Biopharma's Debt / Equity ratio is 0.25.